Your browser doesn't support javascript.
loading
Considerations for de-escalating universal masking in healthcare centers.
Landelle, Caroline; Birgand, Gabriel; Price, James R; Mutters, Nico T; Morgan, Daniel J; Lucet, Jean-Christophe; Kerneis, Solen; Zingg, Walter.
Afiliação
  • Landelle C; University of Grenoble Alpes, CNRS, UMR 5525, Grenoble INP, CHU Grenoble Alpes, Infection Prevention and Control Unit, 38000 Grenoble, France.
  • Birgand G; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at Imperial College London, London, UK.
  • Price JR; Regional Center for Infection Prevention and Control Pays de la Loire, Centre Hospitalier Universitaire de Nantes, Nantes, France.
  • Mutters NT; Brighton and Sussex Medical School, Brighton, UK.
  • Morgan DJ; Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany.
  • Lucet JC; University of Maryland School of Medicine, Baltimore, MD, USA.
  • Kerneis S; VA Maryland Healthcare System, Baltimore, MD, USA.
  • Zingg W; Infection Control Unit, Hôpital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris, Paris, France.
Article em En | MEDLINE | ID: mdl-37592969
ABSTRACT
Three years after the beginning of the COVID-19 pandemic, better knowledge on the transmission of respiratory viral infections (RVI) including the contribution of asymptomatic infections encouraged most healthcare centers to implement universal masking. The evolution of the SARS-CoV-2 epidemiology and improved immunization of the population call for the infection and prevention control community to revisit the masking strategy in healthcare. In this narrative review, we consider factors for de-escalating universal masking in healthcare centers, addressing compliance with the mask policy, local epidemiology, the level of protection provided by medical face masks, the consequences of absenteeism and presenteeism, as well as logistics, costs, and ecological impact. Most current national and international guidelines for mask use are based on the level of community transmission of SARS-CoV-2. Actions are now required to refine future recommendations, such as establishing a list of the most relevant RVI to consider, implement reliable local RVI surveillance, and define thresholds for activating masking strategies. Considering the epidemiological context (measured via sentinel networks or wastewater analysis), and, if not available, considering a time period (winter season) may guide to three gradual levels of masking (i) standard and transmission-based precautions and respiratory etiquette, (ii) systematic face mask wearing when in direct contact with patients, and (iii) universal masking. Cost-effectiveness analysis of the different strategies is warranted in the coming years. Masking is just one element to be considered along with other preventive measures such as staff and patient immunization, and efficient ventilation.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Antimicrob Steward Healthc Epidemiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Antimicrob Steward Healthc Epidemiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França